Pharmaceuticals announced that 23 abstracts, including six oral presentations, showcasing compelling Revuforj and Niktimvo data were accepted for presentation at the 67th American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback